Physician profile
Jared Daniel Ament
NPI 1356653927
$108,535.22
in general payments reported to CMS, 2019-2025
47 companies · $12K in 2025
The $12K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $18K · 2021: $14K · 2022: $1,704 · 2023: $1,978 · 2024: $6,697 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $1,413 · Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,890.48 |
| Travel and Lodging | $1,412.71 |
| Food and Beverage | $1,093.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paradigm Spine, LLC | $45,000.00 | 2019 | |
| 7d Surgical INC. | $15,687.85 | 2020 | |
| Cerapedics INC. | $12,280.23 | 2019-2025 | I-Factor Peptide Enhanced Bone Graft |
| Globus Medical, INC. | $10,257.15 | 2019-2023 | Alif Instruments (Universal) |
| Premia Spine, LTD. | $8,375.00 | 2025 | Tops |
| Spineart USA INC | $6,110.13 | 2019-2025 | |
| Stryker Corporation | $1,810.59 | 2019-2023 | Avaflex, N/A, Spinejack |
| Orthofix Medical, INC. | $1,654.54 | 2021-2024 | M6-C, Shoreline Asc, 7d Surgical System |
| Aesculap Implant Systems, LLC | $1,650.00 | 2020 | |
| Ctl Medical Corporation | $1,367.81 | 2019-2020 | |
| Surgalign Spine Technologies, INC. | $846.94 | 2019-2022 | |
| Abbott Laboratories | $457.97 | 2021-2023 | Infinity |
| Spineart Sa | $351.43 | 2019 | |
| Zimmer Biomet Holdings, INC. | $322.22 | 2019-2021 | |
| Medtronic, INC. | $287.78 | 2021-2025 | Mazor X System |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Ament listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.